← Back to Conditions

Deficiency of pyrroline-5-carboxylate reductase

disorder
SNOMED 124177001CUI C2931835

Overview

Deficiency of pyrroline-5-carboxylate reductase is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Reduced tissue delta-1-pyrroline-5-carboxylate dehydrogenase activity
Always present (100%)HP:6000695
Abnormal cerebrospinal fluid morphology
Very frequent (80-99%)HP:0002921
Abnormal circulating enzyme concentration or activity
Very frequent (80-99%)HP:0012379
Behavioral symptoms
Very frequent (80-99%)HP:0000708
Cognitive delay
Very frequent (80-99%)HP:0001263
Elevated urinary hydroxyproline
Very frequent (80-99%)HP:0003080
Epilepsy
Very frequent (80-99%)HP:0001250
Hyperprolinemia
Very frequent (80-99%)HP:0008358
Increased urine alpha-ketoglutarate concentration
Very frequent (80-99%)HP:0012402
Mental-retardation
Very frequent (80-99%)HP:0001249
Proline high in urine
Very frequent (80-99%)HP:0003137
Chronic extreme exhaustion
Frequent (30-79%)HP:0012432
EEG with generalised sharp slow waves
Frequent (30-79%)HP:0011199
Elevated csf protein
Frequent (30-79%)HP:0002922
Generalised-onset seizure
Frequent (30-79%)HP:0002197
Hyperglycinemia
Frequent (30-79%)HP:0002154
Increased blood alanine
Frequent (30-79%)HP:0003348
Muscle spasm
Frequent (30-79%)HP:0003394
Poor exercise tolerance
Frequent (30-79%)HP:0003546
Reduced vitamin b6 levels
Frequent (30-79%)HP:0008326
Speech delay
Frequent (30-79%)HP:0000750
Trouble sleeping
Frequent (30-79%)HP:0002360
Unsteady walk
Frequent (30-79%)HP:0002317
Absent deep tendon reflexes
Occasional (5-29%)HP:0001284
Anxiety disease
Occasional (5-29%)HP:0000739
ASD
Occasional (5-29%)HP:0000729
Confusion
Occasional (5-29%)HP:0001289
Deglutition disorder
Occasional (5-29%)HP:0002015
Depressive episode
Occasional (5-29%)HP:0000716
Diarrhea
Occasional (5-29%)HP:0002014

Quick Facts

SNOMED CT
124177001
UMLS CUI
C2931835
Fully Specified Name
Deficiency of pyrroline-5-carboxylate reductase (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
30
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.